BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31612979)

  • 1. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
    Heidari E; Varmaghani M; Abdollahiasl A
    East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
    Jiang M; Yang S; Yan K; Liu J; Zhao J; Fang Y
    PLoS One; 2013; 8(8):e70836. PubMed ID: 23936471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
    Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
    BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.
    Nguyen HTT; Dinh DX; Nguyen TD; Nguyen VM
    PLoS One; 2021; 16(11):e0260142. PubMed ID: 34793554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
    Sun X; Wei J; Yao Y; Chen Q; You D; Xu X; Dai J; Yao Y; Sheng J; Li X
    BMJ Open; 2018 Oct; 8(10):e023646. PubMed ID: 30341137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka.
    Dabare PR; Wanigatunge CA; Beneragama BH
    BMC Public Health; 2014 Aug; 14():817. PubMed ID: 25103467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.
    Shambira G; Suleman F
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e11. PubMed ID: 34636605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.
    Ocran Mattila P; Biritwum RB; Babar ZU
    PLoS One; 2023; 18(5):e0279817. PubMed ID: 37134123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability, prices and affordability of selected essential medicines in Jordan: a national survey.
    Alefan Q; Amairi R; Tawalbeh S
    BMC Health Serv Res; 2018 Oct; 18(1):787. PubMed ID: 30340486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
    Osuafor NG; Ukwe CV; Okonta M
    PLoS One; 2021; 16(8):e0255567. PubMed ID: 34383799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China.
    Wang X; Fang Y; Yang S; Jiang M; Yan K; Wu L; Lv B; Shen Q
    PLoS One; 2014; 9(3):e90365. PubMed ID: 24595099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
    Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
    PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
    Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
    Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
    Mattila PO; Babar ZU; Suleman F
    BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.